Mesa Laboratories acquired all of the assets (other than cash and other fixed assets) and certain liabilities of the dental sterilizer testing business of North Bay Bioscience, LLC, according to twst.com
Here are four quick facts:
1. The acquisition is projected to add around $4 million to Mesa's revenues.
2. The majority of NBB's business involves the testing of small table-top sterilizers in the U.S. dental industry.
3. NBB created a unique service in the sterilizer testing industry that tracks the performance of each sterilizer and enables the dental practice to monitor the data online.
4. NBB distributes self-contained biological indicators to dental markets in the United States and Canada for dentists who prefer to perform the testing process in-house.
More dental news:
Drs. Paula Palma, Philip Meeser & more: 6 dentists making headlines
3M acquires Capital Safety, Henry Schein shares rise 0.65% & more: 7 key notes
FDA clears 16 dental devices in July